Hummingbird Diagnostics
Business Services · Germany · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Im Neuenheimer Feld 583, Heidelberg, Bad...Phone Number
+49 62219143310Revenue
$5.9 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Hummingbird Diagnostics
Hummingbird Diagnostics specializes in next-generation molecular blood tests that integrate disease and immune response biomarkers for precision medicine. Their innovative approach aims to enhance early disease detection, response prediction, and treatment monitoring, particularly in cancer care. The company focuses on transforming the diagnosis, treatment, and management of various diseases through personalized medicine. Their intended clients include healthcare providers and researchers in the field of oncology and disease management.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Hummingbird Diagnostics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Hummingbird Diagnostics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Hummingbird Diagnostics recently announced quarterly report
Check out if Hummingbird Diagnostics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Check if Hummingbird Diagnostics has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Hummingbird Diagnostics has new funding data
Product Launch: Get notified when Hummingbird Diagnostics launches new products
Click to see if Hummingbird Diagnostics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Hummingbird Diagnostics
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Hummingbird Diagnostics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Hummingbird Diagnostics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Hummingbird Diagnostics.
Hummingbird Diagnostics Tech Stack
A closer look at the technologies used by Hummingbird Diagnostics
Most Recent Scoops
Lateral Move
Executive Move
Executive Moves, Lateral Move
New Hire
Executive Move
Executive Moves, New Hire
Event
Product Marketing, Events, Training, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Technology
Event
Product Marketing, Events, Software, Field /Outside Sales, Field Marketing, Healthcare Operations, Healthcare Technology
Event
Events
Hummingbird Diagnostics News & Media
Hummingbird Diagnostics Names Vincent Lozada Chief Executive Officer
HEIDELBERG, Germany--(BUSINESS WIRE)--Jan 12, 2026--Hummingbird Diagnostics Product Pipeline Analysis
The "Hummingbird Diagnostics Product Pipeline Analysis" highlights the company’s miRNA-based liquid biopsy innovations for early detection of cancer, cardiovascular, and inflammatory diseases. The "Hummingbird Diagnostics Product Pipeline Analysis" highlights the company’s miRNA-based liquid biopsy innovations for early detection of cancer, cardiovascular, and inflammatory diseases.Hummingbird Diagnostics Announces Publication Evaluating miR-Blood's Small RNA Expression Dataset Capabilities in Nature’s Scientific Data
HEIDELBERG, Germany--(BUSINESS WIRE)--Hummingbird Diagnostics GmbH today announced a publication in Scientific Data evaluating miR-Blood's small RNA expression dataset capabilities.Hummingbird Diagnostics Announces Initiation of Patient Recruitment for Clinical Study Evaluating miLungDx as a Novel Diagnostic Test for Early-stage Lung Cancer
HEIDELBERG, Germany--(BUSINESS WIRE)--Hummingbird Diagnostics GmbH today announced the initiation of its clinical study evaluating the diagnostic performance of miLungDx.
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Hummingbird Diagnostics
Sign Up For FreeTo access detailed company insights
Hummingbird Diagnostics specializes in next-generation molecular blood tests that integrate disease and immune response biomarkers for precision medicine. Their innovative approach aims to enhance early disease detection, response prediction, and treatment monitoring, particularly in cancer care. The company focuses on transforming the diagnosis, t... Read More
